All data are based on the daily closing price as of April 1, 2025
a

ASKA Pharmaceutical Holdings

4886.TSE
15.51 USD
0.06
+0.39%

Overview

Last close
15.51 usd
Market cap
439.30M usd
52 week high
16.49 usd
52 week low
10.96 usd
Target price
16.38 usd

Valuation

P/E
9.9417
Forward P/E
N/A
Price/Sales
1.0322
Price/Book Value
1.0025
Enterprise Value
418.48M usd
EV/Revenue
0.9791
EV/EBITDA
9.1641

Key financials

Revenue TTM
424.88M usd
Gross Profit TTM
176.14M usd
EBITDA TTM
61.13M usd
Earnings per Share
1.41 usd
Dividend
0.13 usd
Total assets
585.32M usd
Net debt
-17.54M usd

About

ASKA Pharmaceutical Holdings Co.,Ltd., through its subsidiaries, engages in the pharmaceutical, animal health, and hormone testing businesses in Japan. The company researches, develops, manufactures, and markets pharmaceutical products in the areas of endocrinology, obstetrics and gynecology, and urology; and researches, manufactures, sells, imports, and exports veterinary medicines, veterinary medical devices, feed and feed additives, reagents, agrochemicals, industrial chemicals, hygiene products, and food products and their raw materials. It is also involved in the clinical examination and biological testing activities; and offers medical devices. ASKA Pharmaceutical Holdings Co.,Ltd. was founded in 1920 and is headquartered in Tokyo, Japan.
  • Symbol
    4886.TSE
  • Exchange
    TSE
  • Isin
    JP3119660003
  • Country
    Japan
  • Sector
    Healthcare
  • Industry
    Drug Manufacturers - Specialty & Generic
  • CEO
  • Headquarter
    Tokyo
  • Web site
    https://www.aska-pharma-hd.co.jp
Jakota Newsletter

Stay ahead in the JAKOTA stock markets with our roundup of vital insights

Icon scroll to top